TURKU, FI / ACCESS Newswire / May 30, 2025 / Faron Pharmaceuticals (HEL:FARON)(LSE:FARN) - Phase I study shows promising clinical activity and tolerability of bexmarilimab plus standard-of-care in ...

Also, a reduction in bone marrow blast cells (immature cells) was seen in 64% of all patients across all doses of bexmarilimab. The study also evaluated the immune response in the bone marrow and ...

TURKU, FI / ACCESS Newswire / May 30, 2025 / Faron Pharmaceuticals (HEL:FARON)(LSE:FARN) - Phase I study shows promising clinical activity and tolerability of bexmarilimab plus standard-of-care in hig ...

Takeda has bolstered its near-term pipeline in rare haematological disorders by licensing rights to a polycythaemia vera (PV) treatment being developed by Protagonist Therapeutics. The Japanese ...

TOMOROW: Tuesday will be pretty similar to Monday in terms of heat. Highs for most of the viewing area will be in the low to mid 90s. Cities in the brush country will approach temperatures in the ...

The heavily armored vehicle is bulletproof, blast-resistant, and sealed to withstand biochemical attacks. While details about the limousine's security measures remain classified, NBC News reported ...

As Trump’s MAGA allies blast a hard-hitting ruling against his tariffs, a lawyer for the challengers explains how it reveals serious weaknesses in their legal justification—and what the ...